20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Hongchao Pan*, Richard Gray, Jeremy Braybrooke, Christina Davies, Carolyn Taylor, Paul McGale, Richard Peto, Kathleen I. Pritchard, Jonas Bergh, Mitch Dowsett, EBCTCG, Petrus Hupperets, Daniel F. Hayes

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1836-1846
Number of pages11
JournalNew England Journal of Medicine
Volume377
Issue number19
DOIs
Publication statusPublished - 9 Nov 2017

Keywords

  • SURGICAL ADJUVANT BREAST
  • LATE DISTANT RECURRENCE
  • CLINICAL-PRACTICE GUIDELINE
  • RANDOMIZED-TRIALS
  • POSTMENOPAUSAL WOMEN
  • TAMOXIFEN THERAPY
  • AMERICAN SOCIETY
  • SCORE
  • DISCONTINUATION
  • CHEMOTHERAPY

Cite this